NCT00263718View on ClinicalTrials.gov

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

December 31, 2005

Study Completion Date

May 31, 2006

Conditions
Psoriasis Vulgaris
Interventions
DRUG

Calcipotriol plus betamethasone dipropionate (LEO 80185) gel

Trial Locations (5)

16268

Läkarhuset Vällingby, Vällingby

N6A3H7

The Guenther Dermatology Research Centre, London

04103

Universitätsklinikum Leipzig, Leipzig

Unknown

Waterford Regional Hospital, Waterford

DD1 9SY

Ninewells Hospital and Medical School, Dundee

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY

NCT00263718 - Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis Vulgaris | Biotech Hunter | Biotech Hunter